Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 173 Records) |
Query Trace: Neoplasms and TYMS[original query] |
---|
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Scientific reports 2019 Aug 9 (1): 11527. Ruzzo Annamaria, Graziano Francesco, Galli Francesca, Galli Fabio, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Bagaloni Irene, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Pharmacological research 2019 Dec 104594. Hamzic Seid, Kummer Dominic, Froehlich Tanja K, Joerger Markus, Aebi Stefan, Palles Claire, Thomlinson Ian, Meulendijks Didier, Schellens Jan H M, García-González Xandra, López-Fernández Luis A, Amstutz Ursula, Largiadèr Carlo |
Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study. OncoTargets and therapy 2019 12 8241-8247. Yao Li, Zhou Linghui, Deng Yujiao, Zheng Yi, Yang Pengtao, Wang Meng, Dong Shanshan, Hao Qian, Xu Peng, Li Na, Wu Ying, Zhai Zhen, Lyu Lijuan, Dai Zhij |
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer. Cancer communications (London, England) 2019 Oct 39 (1): 57. Lin Shaoyan, Yue Jian, Guan Xiuwen, Yuan Peng, Wang Jiayu, Luo Yang, Fan Ying, Cai Ruigang, Li Qiao, Chen Shanshan, Zhang Pin, Li Qing, Ma Fei, Xu Bing |
5-Fluorouracil Conversion Pathway Mutations in Gastric Cancer. Biology 2020 Sep 9 (9): . Biagioni Alessio, Staderini Fabio, Peri Sara, Versienti Giampaolo, Schiavone Nicola, Cianchi Fabio, Papucci Laura, Magnelli Luc |
Significance of expression of pyrimidine metabolizing genes in colon cancer. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2020 8 21 (3): 189-193. Ramadan Ragaa A, Moghazy Thanaa F, Hafez Radwa, Morsi Heba, Samir Mohamed, Shamesya Moham |
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population. Avicenna journal of medical biotechnology 0 12 (3): 157-164. Abbasian Mohammad Hadi, Ansarinejad Nafiseh, Abbasi Bahareh, Iravani Masoud, Ramim Tayeb, Hamedi Fahime, Ardekani Ali |
Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer. Cancer research and treatment 2020 Dec . Dong Si-Qi, Wang Tong-Min, Zhang Jiang-Bo, He Yong-Qiao, Xue Wen-Qiong, Wu Zi-Yi, Yang Da-Wei, Cao Lian-Jing, Huang Jing-Wen, Li Xi-Zhao, Zhang Pei-Fen, Zheng Xiao-Hui, Jia Wei-H |
Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer. Asian Pacific journal of cancer prevention : APJCP 2020 Dec 21 (12): 3751-3759. De Castro Tialfi Bergamin, Rodrigues-Fleming Gabriela Helena, Oliveira-Cucolo Juliana Garcia De, Silva Jéssika Nunes Gomes Da, Silva Fabia Pigatti, Raposo Luiz Sérgio, Maniglia José Victor, Pavarino Erika Cristina, Batista Arantes Lidia Maria Rebolho, Galbiatti-Dias Ana Lívia Silva, Maria Goloni Bertollo E |
Correlation between polymorphism of TYMS gene and toxicity response to treatment with 5-fluoruracil and capecitabine. European journal of translational myology 2020 10 30 (3): 8970. Vitello Stefano, Di Liegro Italia, Ricciardi Maria Rita, Verga Chiara, Amato Alessandra, Schiera Gabriella, Di Liegro Carlo, Messina Giuseppe, Proia Patriz |
A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. Journal of personalized medicine 2020 10 10 (4): . Schaerer Dominic, Froehlich Tanja K, Hamzic Seid, Offer Steven M, Diasio Robert B, Joerger Markus, Amstutz Ursula, Largiadèr Carlo |
Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy. Journal of Cancer 2020 11 (22): 6507-6515. Jiang Lu, Li Shuwei, Yuan Ming, Ma Ling, Lin Yu, Zhu Weiyou, Du Haina, Wang Meilin, Chen Tao, Zhu Lingj |
3'-UTR Polymorphisms in Thymidylate Synthase with Colorectal Cancer Prevalence and Prognosis. Journal of personalized medicine 2021 Jun 11 (6): . Jeon Young-Joo, Cho Sung-Hwan, Kim Eo-Jin, Ryu Chang-Soo, Park Han-Sung, Kim Jong-Woo, Lee Jeong-Yong, An Hui-Jeong, Kim Nam-Ke |
Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine based chemotherapy toxicity. Pharmacogenomics 2021 . Ioannou Charalampia, Ragia Georgia, Balgkouranidou Ioanna, Xenidis Nikolaos, Amarantidis Kyriakos, Koukaki Triantafyllia, Biziota Eirini, Kakolyris Stylianos, Manolopoulos Vangelis |
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics 2021 Jun . Patel Jai N, Jiang Chen, Owzar Kouros, Mulkey Flora, Luzum Jasmine A, Mamon Harvey J, Haller Daniel G, Dragovich Tomislav, Alberts Steven R, Bjarnason Georg, Willet Christopher G, Niedzwiecki Donna, Enzinger Peter, Ratain Mark J, Fuchs Charles, McLeod Howard |
Association between 5'-UTR and 3'-UTR Polymorphisms of the TYMS Gene and Breast Cancer in Kurdish Women of Iraq. Asian Pacific journal of cancer prevention : APJCP 2021 May 22 (5): 1557-1560. Mohamad Kazhal She |
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes. The pharmacogenomics journal 2021 Mar . O'Connell E, Reynolds I S, Salvucci M, McNamara D A, Burke J P, Prehn J H |
Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low. Breast cancer research and treatment 2021 Feb . Cao Shang, Zhu Zheng, Zhou Jinyi, Li Wei, Dong Yunqiu, Qian Yun, Wei Pingmin, Wu Mi |
A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer. Experimental biology and medicine (Maywood, N.J.) 2021 10 247 (2): 120-130. Chen Qiangda, Pu Ning, Yin Hanlin, Zhang Jicheng, Zhao Guochao, Lou Wenhui, Wu Wenchu |
Variants of Genes Involved in Metabolism of Folate Among Patients with Breast Cancer: Association of TYMS 3R Allele with Susceptibility to Breast Cancer and Metastasis. Iranian journal of pathology 2021 16 (1): 62-68. Rahimi Zohreh, Bozorgi Zarini Maryam, Rahimi Ziba, Shakiba Ebrahim, Vaisi-Raygani Asad, Moradi Mohammad Taher, Yari Kheirol |
DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of chemotherapy (Florence, Italy) 2022 Sep 1-10. Khalij Yassine, Belaid Imtinen, Chouchane Sana, Amor Dorra, Omezzine Asma, Ben Rejeb Nabila, Ben Ahmed Slim, Bouslama A |
A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. Frontiers in endocrinology 2022 8 13 975623. Wang Yuliang, Fan Jiaqi, Chen Tao, Xu Lele, Liu Pengyu, Xiao Lijia, Wu Tao, Zhou Qingchun, Zheng Qingyou, Liu Chunxiao, Chan Franky Leung, Wu Dingl |
TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients. Pharmaceutics 2021 Dec 14 (1): . Emelyanova Marina, Pokataev Ilya, Shashkov Igor, Kopantseva Elena, Lyadov Vladimir, Heydarov Rustam, Mikhailovich Vladim |
Prediction of lung cancer risk in Chinese population with genetic-environment factor using extreme gradient boosting. Cancer medicine 2022 May . Li Yutao, Zou Zixiu, Gao Zhunyi, Wang Yi, Xiao Man, Xu Chang, Jiang Gengxi, Wang Haijian, Jin Li, Wang Jiucun, Wang Huai Zhou, Guo Shicheng, Wu Junj |
The role of gender pharmacogenetics in the personalization of drug treatment. The Journal of pharmacology and experimental therapeutics 2023 3 . Cecchin Erika, Posocco Bianca, Mezzalira Silvia, Appetecchia Marialuisa, Toffoli Giusep |
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer. Cancer chemotherapy and pharmacology 2023 10 . Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An |
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece. Frontiers in pharmacology 2023 10 14 1248898. Georgia Ragia, Anthi Maslarinou, Natalia Atzemian, Eirini Biziota, Triantafyllia Koukaki, Charalampia Ioannou, Ioanna Balgkouranidou, George Kolios, Stylianos Kakolyris, Nikolaos Xenidis, Kyriakos Amarantidis, Vangelis G Manolopoul |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 05, 2023
- Content source: